Építés alatt – nem éles oldal
Belépés
Befejeződött1. fázis

The Attractive 2 trial – An open-label, randomised, 2-period cross-over trial to assess the pharmacokinetics of ATR-258 oral capsule vs. oral solution formulations in healthy volunteers

Key facts

Where
Uppsala, SvédországSee the site
Phase
1. fázis

Where in Svédország

  • CTC Clinical Trial Consultants ABUppsala, SvédországNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Atrogi AB
Trial code
EU 2023-508797-28-00
Record updated
2024. február 22.